Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2005

Jan 4, 2005

29777_dirs_2005-01-04_1b6fc012-c5d9-49a3-8a29-e09107602c30.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2004-12-17

Reporting Person: POWELL BOONE JR (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2004-12-17 Common shares without par value G 550 Disposed 33157 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2004-12-31 Stock equivalent units $0 A 267 Acquired common shares (267) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 700 Indirect
Common shares without par value 1500 Indirect

Footnotes

F1: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.